Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jian-Ge

Showing results (651-660 of 657) with videos related to

Pageof 66
Sort By:
You have reached the last page of results.This site can display upto 657 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 25, 2025
A Human Immuno-Lung Organoid Model to Study Macrophage-Mediated Lung Cell Senescence Upon SARS-CoV-2 InfectionYuling Han, Dongliang Leng, Tuo Zhang, et al.
International Journal of Surgery (London, England)|September 23, 2024
Radiation-emitting metallic stent for unresectable Bismuth type III or IV perihilar cholangiocarcinoma: a multicenter randomized trialQi Chen, Nai-Jian Ge, Yu-Liang Li, et al.
American Journal of Hematology|December 13, 2025
Long-Term Outcomes of a Stratified Treatment Regimen Based on Etoposide and Glucocorticoids in Children With Hemophagocytic Lymphohistiocytosis (CCHG-HLH-2018): A Multicenter, Single-Arm Clinical StudyZishi Fang, Jie Yu, Wei Liu, et al.
Frontiers in Pharmacology|August 2, 2021
Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular CarcinomaZhong-Kun Xia, Wei Wang, Jian-Ge Qiu, et al.
Cancer Pathogenesis and Therapy|July 23, 2025
Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone diseaseYutong Wang, Qiming Xu, Yuan Li, et al.
Eclinicalmedicine|May 15, 2024
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation studyZhi-Cheng Jin, Jian-Jian Chen, Xiao-Li Zhu, et al.
Signal Transduction and Targeted Therapy|February 8, 2023
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, et al.
Pageof 66

Showing results (651-660 of 657) with videos related to

Sort By:
Pageof 66
You have reached the last page of results.This site can display upto 657 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 25, 2025
A Human Immuno-Lung Organoid Model to Study Macrophage-Mediated Lung Cell Senescence Upon SARS-CoV-2 InfectionYuling Han, Dongliang Leng, Tuo Zhang, et al.
International Journal of Surgery (London, England)|September 23, 2024
Radiation-emitting metallic stent for unresectable Bismuth type III or IV perihilar cholangiocarcinoma: a multicenter randomized trialQi Chen, Nai-Jian Ge, Yu-Liang Li, et al.
American Journal of Hematology|December 13, 2025
Long-Term Outcomes of a Stratified Treatment Regimen Based on Etoposide and Glucocorticoids in Children With Hemophagocytic Lymphohistiocytosis (CCHG-HLH-2018): A Multicenter, Single-Arm Clinical StudyZishi Fang, Jie Yu, Wei Liu, et al.
Frontiers in Pharmacology|August 2, 2021
Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular CarcinomaZhong-Kun Xia, Wei Wang, Jian-Ge Qiu, et al.
Cancer Pathogenesis and Therapy|July 23, 2025
Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone diseaseYutong Wang, Qiming Xu, Yuan Li, et al.
Eclinicalmedicine|May 15, 2024
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation studyZhi-Cheng Jin, Jian-Jian Chen, Xiao-Li Zhu, et al.
Signal Transduction and Targeted Therapy|February 8, 2023
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, et al.
Pageof 66